# Use of Autologous Concentrated Bone Marrow Aspirate in Preventing Wound Complications in Below Knee Amputation (BKA)

> **NCT02863926** · PHASE1 · COMPLETED · sponsor: **Michael Murphy** · enrollment: 6 (actual)

## Conditions studied

- Peripheral Artery Disease
- Vascular Disease
- Critical Limb Ischemia

## Interventions

- **BIOLOGICAL:** Injection of cBMA aspirate into the index leg

## Key facts

- **NCT ID:** NCT02863926
- **Lead sponsor:** Michael Murphy
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-06
- **Primary completion:** 2018-07-27
- **Final completion:** 2018-07-27
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2024-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02863926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02863926, "Use of Autologous Concentrated Bone Marrow Aspirate in Preventing Wound Complications in Below Knee Amputation (BKA)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02863926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*